Oramed Ltd.
14Patents
9Active
14Granted
41Portfolio score
Filing activity: Aug 21, 1990 → Dec 23, 2020 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5102666A | Calcium polycarbophil controlled release composition and method | Human Necessities | 56 | Expired |
| US5110605A | Calcium polycarbophil-alginate controlled release composition and method | Human Necessities | 49 | Expired |
| US5741805A | Controlled release pilocarpine delivery system | Human Necessities | 7 | Expired |
| US5731338A | Controlled release pilocarpine delivery system | Human Necessities | 7 | Expired |
| US5661171A | Controlled release pilocarpine delivery system | Human Necessities | 5 | Expired |
| US10350162B2 | Methods and compositions for oral administration of exenatide | Human Necessities | 4 | Active |
| US10398762B2 | Methods and compositions for treating diabetes | Human Necessities | 4 | Active |
| US10058593B2 | Methods and compositions for oral administration of proteins | Human Necessities | 4 | Active |
| US10342764B2 | Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same | Human Necessities | 4 | Active |
| US10881714B2 | Methods and compositions for oral administration of proteins | Human Necessities | 1 | Active |
| US10967051B2 | Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof | Human Necessities | 0 | Active |
| US11660327B2 | Methods and compositions for oral administration of proteins | Human Necessities | 0 | Active |
| US11395848B2 | Methods and compositions for treating diabetes | Human Necessities | 0 | Active |
| US10933022B2 | Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.